Mortality due to cirrhosis has been increasing in the US since 2009, with individuals aged 25-34 years experiencing the greatest relative increase in mortality due to deaths from alcoholic cirrhosis, a recent study found. The observational cohort study included death certificate data from the Vital Statistics Cooperative, and population data from the US Census Bureau compiled by the Centers for Disease Control and Prevention’s Wide-ranging Online Data for Epidemiologic Research (1999-2016). The primary outcome measure was deaths from cirrhosis and hepatocellular carcinoma (HCC), with trends evaluated using joinpoint regression. Researchers found:
- From 1999 to 2016 in the US, annual deaths from cirrhosis increased by 65%, while annual deaths from HCC doubled.
- People aged 25-34 have experienced the greatest relative increase in mortality, driven by deaths due to alcoholic cirrhosis.
- During the study period, white Americans, Native Americans, and Hispanic Americans experienced the greatest increase in deaths from cirrhosis.
Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: Observational study. [Published online ahead of print July 18, 2018]. BMJ. doi:10.1136/bmj.k2817.
This Week's Must Reads
Acute Illness and Cannabis Use in Adults, Ann Intern Med; ePub 2019 Mar 26; Monte, et al
Pregnancy History and Risk of Miscarriage, BMJ; ePub 2019 Mar 20; Magnus, et al
Firearms Mortality Among US Schoolchildren, Am J Med; ePub 2019 Mar 25; Rubenstein, et al
Rapid Point of Care Test for Influenza, J Am Board Fam Med; 2019 Mar; Dale, et al
Sleep Disturbance and Chronic Pain Intensity, Clin J Pain; ePub 2019 Mar 25; Burgess, et al
Must Reads in Gastroenterology
Psychological Screening for Youth with Abdominal Pain, Pediatrics; ePub 2018 Jul 25; Cunningham, et al
Mortality Due to Cirrhosis & Liver Cancer in the US, BMJ; ePub 2018 Jul 18; Tapper, Parikh
Marijuana Use in Adolescents with IBD, J Pediatr; ePub 2018 Apr 16; Hoffenberg, et al
Oral Capsule vs Colonoscopy FMT for CDI, JAMA; 2017 Nov 28; Kao, Roach, et al
Tofacitinib as Induction & Maintenance Therapy, N Engl J Med; 2017 May 4; Sandborn, et al